In a word, our results demonstrated for the first time that human resistin acted on cell cycle of myoblasts, inhibited myogenic differentiation, and promoted proliferation of myoblasts, which may be relevant to the glucose metabolic disorder. This evidence concerns the gene RETN and glucose metabolism disease.